Nexium 20mg

DRUG2 trials

Sponsors

Yooyoung Pharmaceutical Co., Ltd., AstraZeneca

Conditions

Erosive EsophagitisNon-erosive Reflux Disease

Phase 3

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

CompletedNCT03967886

Yooyoung Pharmaceutical Co., Ltd.Non-erosive Reflux Disease

Start: 2019-04-10End: 2020-05-27Updated: 2021-05-11

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

Active, not recruitingNCT05267613

AstraZenecaErosive Esophagitis

Start: 2022-07-01End: 2026-08-19Updated: 2026-07-27